Wenseng Pan

Practice Areas

Dr. Wenseng “Wendy” Pan, leader of Goodwin’s Life Sciences practice in Asia, specializes in mergers and acquisitions, technology-based transactions, licensing and strategic partnerships as well as financing transactions (including both venture/private equity financings and IPOs), especially in the life sciences and technology industries and in cross-border settings.

She has advised private equity firms in leveraged buy-outs and has represented financial institutions, technology, media and telecoms (TMT), biopharmaceutical, manufacturing, publishing, electronics companies and retail chains in stock and/or cash acquisitions, mergers, tender offers and going-private transactions. Wendy has advised on mergers and acquisitions transactions with an aggregate value over US $10 billion. She also advises on company formation, corporate governance, private and public financings.

Personal

J.D., Columbia University School of Law, 1998 (Harlan Fiske Stone Scholar); Ph.D., Chemistry, Columbia University, 1995 (Pegram Award); B.S., Fudan University, 1989 (First Class honors).